Enterome
PrivateLast Round
VC Round
Jun 12, 2025
Total Funding Raised
$179.97M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Enterome is a biotechnology company that develops immunomodulatory drugs and therapeutic vaccines for cancer and immune-related diseases based on its proprietary gut microbiome-derived Mimicry platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enterome Comparables
Compare Enterome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exeliom Biosciences | 78% | |
| MaaT Pharma | 78% | |
| Vedanta Biosciences | 74% | |
Enterome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 12, 2025 | ||||
| VC Round | Jun 12, 2024 | ||||
| Early Funding | Aug 25, 2023 | ||||
| Series E | Jun 25, 2020 | ||||
| Series D | Jan 4, 2018 | ||||
Debt | Jan 4, 2018 |
Key People
Founding team and executive leadership
Enterome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lundbeck Foundation | Series D, Series B, Series A, Series C |
| Natixis | VC Round, Series D, Series B, Series E, Series A |
| SymBiosis Capital Management | Series E, VC Round |
| Lundbeckfonden BioCapital | VC Round |
| INRAE Transfert | Seed, Series C |
| European Investment Bank Group | Debt |
| Primo Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 29, 2026
Mehrdad Mobasher, M.D., M.P.H. joins the Board of Directors.
- Jun 12, 2025
$19M round led by Institute for Follicular Lymphoma Innovation
Enterome Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enterome's valuation, stock price, and market status.